How much revenue does Sakar Healthcare make?

Sakar Healthcare reported 1.78 billion INR in revenue for fiscal year 2025. In Q3 2026 revenue was 703.42 million INR.

Where does Sakar Healthcare make most of its revenue?

Export: 55% of revenue by region in fiscal year 2025, followed by India (45%).

What companies are similar to Sakar Healthcare?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Venus Remedies Limited (VENUSREM.NS), Panacea Biotec Limited (PANACEABIO.NS), Indoco Remedies Limited (INDOCO.NS), Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS).

Sakar Healthcare Limited (SAKAR.NS) Stock

About Sakar Healthcare Limited

Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company offers general and oncology products in various forms, such as liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. It also exports its products to Southeast Asia...

At a glance

Sakar Healthcare reported revenue of 1.78 billion INR for fiscal year 2025, and net income of 175.02 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 703.42 million INR, up 62.0% from a year before. Export was its largest region in fiscal year 2025, with 55% of revenue.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.